Tüdőrák: vizsgálatok itt: Spanyolország
275 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleStudy of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients
- Where
- A Coruña, Alicante, Badalona, Barcelona, Bilbao, Ciudad Real, Ferrol, Girona, Las Palmas de Gran Canaria, Lugo, Madrid, Majadahonda, Oviedo, Santa Cruz de Tenerife, Seville, Valencia, Valladolid, Vigo
- Életkor
- 18 év and over
- People
- 50
- Run by
- Fundación GECP
See details and how to joinNCT06634199 - 1/2. fázisTaking peoplePhase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 43 worldwide
- Run by
- One-carbon Therapeutics AB
See details and how to joinNCT07151040 · EU 2024-519639-40-00 - 3. fázisTaking peopleA Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
- Where
- Almería, Badajoz, Badalona, Barcelona, Jaén, Madrid, Málaga, Palma, Valencia
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Maia Biotechnology
See details and how to joinNCT06908304 · EU 2024-520164-33-00 - 1/2. fázisNot yet taking people in SpanyolországPhase 1b/2 Trial of OMTX705, an Anti-Fibroblast Activation Protein Antibody-Drug Conjugate, in Combination with Carboplatin, Pemetrexed and Tislelizumab in Patients with Advanced/Metastatic Non-squamous Non-Small Cell Lung Cancer
- Where
- Barcelona, Fuenlabrada, Jerez de la Frontera, Leganés, Madrid, Málaga, Palma, Santiago de Compostela, Sevilla
- Életkor
- 18 év to 64 év
- People
- 88
- Run by
- Oncomatryx Biopharma S.L.
See details and how to join2025-521989-95-00 - No phaseNot yet taking people in SpanyolországNeutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
- Where
- Seville
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- OncoHost Ltd.
See details and how to joinNCT07246759 - 2. fázisTaking peoplePALACE: Cemiplimab Trial According to ctDNA Levels
- Where
- A Coruña, Alicante, Badalona, Barcelona, Bilbao, Elche, Girona, Jerez de la Frontera, Las Palmas De Gran Canaria, Leganés, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Palma, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 63
- Run by
- Fundación GECP
See details and how to joinNCT06917573 · EU 2024-518812-38-00 - 2. fázisTaking peopleNeoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)
- Where
- A Coruña, Alicante, Badalona, Barcelona, Bilbao, Girona, Granada, Jerez de la Frontera, Las Palmas De Gran Canaria, Lugo, Madrid, Majadahonda, Palma, Pamplona, Reus, Sabadell, Salamanca, Santa Cruz de Tenerife, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 97
- Run by
- Fundación GECP
See details and how to joinNCT07153445 · EU 2024-515984-68-00 - No phaseTaking peopleFissios© and Postoperative Complications (FPoC Trial)
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 560
- Run by
- Carlos Alfredo Fraile Olivero, MD, PhD.
See details and how to joinNCT06732193 - No phaseNot yet taking people in SpanyolországEMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Hedera Dx SA
See details and how to joinNCT07096258 - 1/2. fázisTaking peopleFIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06669117 · EU 2024-512760-64-00 - 2. fázisTaking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peopleEarly Palliative Care in Patients With Advanced Lung Cancer Using an e-Health Ecosystem
- Where
- Badalona, L'Hospitalet de Llobregat
- Életkor
- 18 év and over
- People
- 200
- Run by
- Jesús González
See details and how to joinNCT07039994 - 3. fázisTaking peopleMaintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
- Where
- Barcelona, Madrid, Málaga, Sevilla
- Életkor
- 18 év and over
- People
- 1166 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05692999 · EU 2023-503481-23-00 - No phaseCsak meghívásosLiquid BiOpsy, Lung and Colon Cancer in AndaluciA
- Where
- Granada
- Életkor
- 18 év and over
- People
- 500
- Run by
- Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
See details and how to joinNCT06997458 - 1/2. fázisTaking peopleCisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
- Where
- Barcelona, Madrid, Seville
- Életkor
- 18 év and over
- People
- 32 worldwide
- Run by
- Inhatarget Therapeutics
See details and how to joinNCT06896890 - 1. fázisBefejeződöttStudy of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
- Where
- Madrid, Málaga, Sevilla, Valencia
- Életkor
- 18 év to 75 év
- People
- 190 worldwide
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT06613009 · EU 2025-523972-21-00 - 2. fázisTaking peopleEvaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 40
- Run by
- Vall d'Hebron Institute of Oncology
See details and how to joinNCT06630611 - No phaseTaking peopleFirst in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System
- Where
- Salamanca
- Életkor
- 18 év to 80 év
- People
- 15 worldwide
- Run by
- Snipe Medical
See details and how to joinNCT06423690 - No phaseTaking peopleThe Impact of Radiotherapy on Oligometastatic Cancer
- Where
- Albacete, Barcelona, Castellon, Girona, Granada, Lleida, Madrid, Reus, Seville, Terrassa, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 2000
- Run by
- Institut Investigacio Sanitaria Pere Virgili
See details and how to joinNCT05933876 - No phaseTaking peopleDEPRECAP: Lung Cancer Screening Programme by LDCT for Patients With COPD or Emphysema.
- Where
- Madrid
- Életkor
- 55 év to 75 év
- People
- 1998
- Run by
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT06690385 - No phaseTaking peopleHigh Definition Medicine for Solid Tumors Oncology
- Where
- A Coruña, Barcelona, Cáceres, Fuenlabrada, Madrid, Palma de Mallorca, Pamplona, Seville, Valencia
- Életkor
- 18 év and over
- People
- 300
- Run by
- Centro Nacional de Investigaciones Oncologicas CARLOS III
See details and how to joinNCT06590506 - No phaseNot yet taking people in SpanyolországUnderstanding Lung Cancer Related Risk Factors and Their Impact
- Where
- Barakaldo, Seville
- Életkor
- 40 év to 80 év
- People
- 6160 worldwide
- Run by
- Biobizkaia Health Research Institute
See details and how to joinNCT06473870 - No phaseTaking peopleRegistry of the Spanish Society of Thoracic Surgery
- Where
- Zaragoza
- People
- 30 000
- Run by
- Sociedad Española de Cirugía Torácica
See details and how to joinNCT05600569 - No phaseTaking peopleI3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 2200 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05537922 - 1/2. fázisTaking peopleSPRING Rollover
- Where
- Barcelona
- Életkor
- 65 év and over
- People
- 1
- Run by
- Worldwide Innovative Network
See details and how to join2022-500041-24-00